Literature DB >> 17712857

Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.

Eng-King Tan1, Justina Tong, Ratnagopal Pavanni, Meng-Cheong Wong, Yi Zhao.   

Abstract

Anecdotal reports suggest that patients with spinocerebellar ataxia (SCA 2) patients can present with postural tremor with ataxia. We determined the prevalence of SCA2 and SCA3 mutations in a cohort of ET and atypical Parkinsonism patients. A total of 277 subjects comprising of 177 ET and 100 atypical Parkinsonism were examined. We identified one positive case of SCA3 among those who were diagnosed with ET, yielding a prevalence of 0.5%, but a zero prevalence among our atypical Parkinsonism patients. No study subjects carried an abnormal SCA2 repeat expansion. Our study highlights that SCA3 can present initially with ET symptoms, expanding the spectrum of genetic diseases that can be associated with ET-like phenotype. Routine screening for SCA2 and SCA3 in ET and atypical Parkinsonism patients may not be cost effective. However, in the long-term follow-up of patients who present with an ET phenotype, clinicians should be vigilant for other neurological signs, which may be point to an alternate diagnosis. 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712857     DOI: 10.1002/mds.21699

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  Tremor-spectrum in spinocerebellar ataxia type 3.

Authors:  Cecilia Bonnet; Emmanuelle Apartis; Mathieu Anheim; Andre P Legrand; Jose F Baizabal-Carvallo; Anne M Bonnet; Alexandra Durr; Marie Vidailhet
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

2.  Genetic analysis of ten common degenerative hereditary ataxia loci in patients with essential tremor.

Authors:  L N Clark; X Ye; X Liu; K Mirzozoda; E D Louis
Journal:  Parkinsonism Relat Disord       Date:  2015-06-06       Impact factor: 4.891

Review 3.  Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective.

Authors:  Jia Nee Foo; Jianjun Liu; Eng-King Tan
Journal:  Hum Genet       Date:  2013-03-23       Impact factor: 4.132

Review 4.  Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.

Authors:  Antoni Matilla-Dueñas; Ivelisse Sánchez; Marc Corral-Juan; Antoni Dávalos; Ramiro Alvarez; Pilar Latorre
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

Review 5.  Another Perspective on Fasciculations: When is it not Caused by the Classic form of Amyotrophic Lateral Sclerosis or Progressive Spinal Atrophy?

Authors:  Marco Antonio Araujo Leite; Marco Orsini; Marcos R G de Freitas; João Santos Pereira; Fábio Henrique Porto Gobbi; Victor Hugo Bastos; Dionis de Castro Machado; Sergio Machado; Oscar Arrias-Carrion; Jano Alves de Souza; Acary Bulle Oliveira
Journal:  Neurol Int       Date:  2014-08-08

Review 6.  Parkinsonism in spinocerebellar ataxia.

Authors:  Hyeyoung Park; Han-Joon Kim; Beom S Jeon
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

Review 7.  Etiologic links between environmental and lifestyle factors and Essential tremor.

Authors:  Yi-Lin Ong; Xiao Deng; Eng-King Tan
Journal:  Ann Clin Transl Neurol       Date:  2019-05-01       Impact factor: 4.511

Review 8.  Genomic Markers for Essential Tremor.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; Ignacio Álvarez; Pau Pastor; José A G Agúndez
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

9.  Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.

Authors:  Shi-Rui Gan; Jie Wang; Karla P Figueroa; Stefan M Pulst; Darya Tomishon; Danielle Lee; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Tetsuo Ashizawa; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-10-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.